You are here

NexImmune

Biotechs reveal layoffs, research revamps in third quarter earnings

BioPharma Dive

Wed, 11/16/22 - 11:13 pm

Freeline Therapeutics

Harpoon Therapeutics

Adamis Pharmaceuticals

NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers

BioSpace

Thu, 07/14/22 - 08:01 pm

HPV-related cancer

A pair of biotechs prepares to hit Nasdaq, as total 2021 IPO raise quickly approaches $3B

Endpoints

Sat, 02/13/21 - 11:10 pm

Decibel Therapeutics

IPO tracker: 2021 gets started with a flurry of new offerings

Endpoints

Mon, 01/25/21 - 10:43 am

Sana Biotechnology

Sensei Biotherapeutics

Bolt Biotherapeutics

Terns Pharmaceuticals

Gracell Biotechnologies

Cullinan Oncology

After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO

Fierce Biotech

Thu, 01/21/21 - 10:32 am

Gilead Sciences

Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins

Endpoints

Tue, 01/2/18 - 11:28 am

immuno-oncology